This presentation delves into the critical challenges of bioassay development for multi-specific biologics, addressing key complexities. Experts from WuXi Biologics’ Bioassay Centre of Excellence (BCOE) showcase innovative strategies through real-world case studies, including the bioassay development of bispecific T-cell engagers and multi-specific probodies. Leveraging expertise in bioactivity method development, BCOE provides end-to-end CMC service and flexible standalone services…
Date:
More like thisRelated
Cyberrisico’s zetten bedrijfscontinuïteit het meest onder druk
AuthorTechzine RedactieMaar liefst 48 procent van de bedrijven verwacht...
Beyond the Device: Cyber Asset Intelligence for the AI Agent Explosion
As AI agents proliferate across the enterprise, they're creating...
Optimize cloud efficiency with Red Hat Enterprise Linux for AWS
Organizations need to run their existing systems while preparing...
Effectively manage AWS cloud environments with Red Hat Lightspeed
Enterprises depend on the cloud to store data and...